학술논문
Conversion from calcineurin inhibitors to belatacept-based immunosuppressive therapy skews terminal proliferation of non-classical monocytes and lowers lymphocyte counts
Document Type
Article
Author
Source
In Transplant Immunology February 2024 82
Subject
Language
ISSN
0966-3274